Evidence map›Paper›PMID 19343061›Full record

ArticleActa pharmacologica Sinica2009

Gene expression profiles of human liver cells mediated by hepatitis B virus X protein.

Wei-ying Zhang, Fu-qing Xu, Chang-liang Shan, Rong Xiang, Li-hong Ye, Xiao-dong Zhang

Open access · bronzeAbstract read
In one paragraph

Article in Acta pharmacologica Sinica, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 28 citations in OpenAlex.

  1. Review
  2. Deregulation of Frizzled Receptors in Hepatocellular Carcinoma.International journal of molecular sciences · 2018
    Review
  3. Article
  4. Article
  5. Article
  6. Hepatitis B Virus X and Regulation of Viral Gene Expression.Cold Spring Harbor perspectives in medicine · 2016
    Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Wei-ying ZhangDepartment of Cancer Research, Key Laboratory of Molecular Microbiology and Technology of Ministry of Education, Institute for Molecular Biology, College of Life Sciences, Nankai University, Tianjin, China.
Fu-qing Xu
Chang-liang Shan
Rong Xiang
Li-hong Ye
Xiao-dong Zhang
Nankai University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimTo demonstrate the gene expression profiles mediated by hepatitis B virus X protein (HBx), we characterized the molecular features of pathogenesis associated with HBx in a human liver cell model.

methodsWe examined gene expression profiles in L-O2-X cells, an engineered L-O2 cell line that constitutively expresses HBx, relative to L-O2 cells using an Agilent 22 K human 70-mer oligonucleotide microarray representing more than 21,329 unique, well-characterized Homo sapiens genes. Western blot analysis and RNA interference (RNAi) targeting HBx mRNA validated the overexpression of proliferating cell nuclear antigen (PCNA) and Bcl-2 in L-O2-X cells. Meanwhile, the BrdU incorporation assay was used to test cell proliferation mediated by upregulated cyclooxygenase-2 (COX-2).

resultsThe microarray showed that the expression levels of 152 genes were remarkably altered; 82 of the genes were upregulated and 70 genes were downregulated in L-O2-X cells. The altered genes were associated with signal transduction pathways, cell cycle, metastasis, transcriptional regulation, immune response, metabolism, and other processes. PCNA and Bcl-2 were upregulated in L-O2-X cells. Furthermore, we found that COX-2 upregulation in L-O2-X cells enhanced proliferation using the BrdU incorporation assay, whereas indomethacin (an inhibitor of COX-2) abolished the promotion.

conclusionOur findings provide new evidence that HBx is able to regulate many genes that may be involved in the carcinogenesis. These regulated genes mediated by HBx may serve as molecular targets for the prevention and treatment of hepatocellular carcinoma.

Indexed as

Gene Expression ProfilingCell Cycle ProteinsCell LineCell ProliferationChemokine CCL5Cyclooxygenase 2Frizzled ReceptorsGADD45 ProteinsHumansLamininLiverNuclear ProteinsOligonucleotide Array Sequence AnalysisProliferating Cell Nuclear AntigenProto-Oncogene Proteins c-bcl-2Receptors, G-Protein-CoupledCCL5 protein, humanCell Cycle ProteinsChemokine CCL5Cyclooxygenase 2Frizzled ReceptorsFZD10 protein, humanGADD45A protein, humanGADD45 Proteinshepatitis B virus X proteinLAMA4 protein, humanLamininNuclear ProteinsProliferating Cell Nuclear AntigenProto-Oncogene Proteins c-bcl-2PTGS2 protein, humanReceptors, G-Protein-CoupledTrans-ActivatorsViral Regulatory and Accessory Proteins

Identifiers

PMID19343061
PMCPMC4002275
OpenAlexW2004481089

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.